MedTrace Logo

Transpacific TAVR Registry

NCT03826264 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-01-02

No results posted yet for this study

Summary

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Conditions

  • Heart Valve Diseases
  • Aortic Valve Insufficiency

Interventions

PROCEDURE

TAVR

transcatheter aortic valve replacement (TAVR)

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Duk-Woo Park, MD

    lead OTHER

Principal Investigators

  • Alan Ching Yuen Yeung, MD · Stanford University

  • James D. Flaherty, MD · Northwestern University

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-15
Primary Completion
2035-12-31
Completion
2036-12-31

Countries

  • United States
  • China
  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826264 on ClinicalTrials.gov